NCT02785835

Hepatocellular Carcinoma in HIV-infected Patients

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 477 (actual)
• Sponsor: Hospital Universitario de Valme · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Observational study. All HIV-infected patients who have been diagnosed of hepatocellular carcinoma (HCC), following the American Association for the Study of Liver Diseases (AASLD) criteria, in the participant centers are included. Epidemiological, clinical and laboratory data are collected. The clinical and epidemiological characteristics of HCC cases will be analyzed. The efficacy and outcomes after modalities of HCC therapy will be assessed. Mortality and its predictors will be also assessed. In those cases infected by hepatitis C virus (HCV), the impact of HCV therapy on outcomes will be analysed.

Conditions

• Hepatocellular Carcinoma
• HIV
• Chronic Hepatitis C
• Hepatitis B Virus
• Liver Cirrhosis

Timeline

• Start date: 2014-05-01
• Primary completion: 2021-06-30
• Completion: 2021-06-30
• First posted: 2016-05-30
• Last updated: 2022-03-16

Locations

30 sites across 1 country: Spain